Latest Funds Management News

Loftus Peak Global Disruption Fund delivered benchmark-beating returns in both its unhedged and hedged classes during the year ended 30 June 2026, while net assets expanded by roughly 44% to $936.7 million. The strong result came with larger distributions and higher performance-related costs, alongside the market exposure inherent in its global equity strategy.

Crimson Consulting has extended its A$0.73-a-share offer for Kip McGrath to 14 October and says it now has a path to control the company with just over half the register. The bidder says support and intentions represent 50.89% of shares, although part of that figure remains conditional.

Marlin Global delivered a 3.0% gross performance return in August, beating its benchmark as software holdings rebounded sharply. The Fisher Funds-managed portfolio is also preparing to exit some investments and add businesses in three sectors.

La Trobe Private Credit Fund has confirmed a monthly cash distribution of 1.27 cents per unit, with payment due on 14 September. Unitholders can instead reinvest through a full DRP at an ex-distribution NTA price of $1.96 per unit.

Savana US Small Caps Active ETF (ASX:SVNP) reversed last year’s loss to deliver a AUD 1.37 million profit for FY 2026, lifting net assets to AUD 5.94 million amid steady investor inflows and solid US small cap equity performance.

Mount Hope Mining has advanced its Mt Solitary gold project with strong drilling results and metallurgical testwork, aiming for a maiden JORC Mineral Resource Estimate by the end of 2026.

Pengana International Equities (ASX: PIA) posted a sharp 82% plunge in net profit for FY26, triggering a strategic board reshuffle and a capital management package including a special dividend and buy-back proposal.

Salter Brothers Emerging Companies Limited (ASX:SB2) swung to a $7.9 million loss for FY26, driven by a $10.5 million investment write-down, while maintaining dividend payments and extending its share buy-back program.

Aland Equity Group’s subsidiary has formalised a Management Rights Agreement for 56 residential lots at Elm Grove Heights, Bungendore, setting the stage for its first property funds income and a sales campaign starting September 2026.

OncoSil Medical lifted revenues 44% in FY26 to $1.68 million and trimmed losses by 28% to $10.86 million, buoyed by key regulatory approvals including FDA HDE and Australian TGA listings. The company is poised for commercial launches in the US and Australia, with strong clinical data underpinning its growth.

Dexus has delivered a 37.0 cents per security distribution for FY26, matching guidance despite economic headwinds, while initiating a strategic review of infrastructure funds acquired in 2023 and forecasting lower earnings in FY27.

Teaminvest Private Group (ASX: TIP) posted a 19% increase in statutory profit for FY26, driven by strong active portfolio growth and disciplined capital allocation, while preparing to acquire Intelligent Investor in an earnings accretive deal.